Findings

What do systematic reviews say?

47 questions · 47 findings · 4 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 14 · 29.8%GRADE not reported 0 · 0%Very low 12 · 25.5%Low 5 · 10.6%Moderate 7 · 14.9%High 9 · 19.1%

Intervention not reported

Specimen · children with presumed pulmonary tuberculosis Index tests: Xpert Ultra Role: an initial test Threshold for index tests: an automated…

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

All specimens · children with presumed pulmonary tuberculosis Index tests: Xpert Ultra Role: an initial test Threshold for index tests: an automated…

1 finding from 1 review

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children 2022 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 3 participants
Very low

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Xpert MTB/RIF, people living with HIV · people living with HIV and non‐hospitalized people in high‐risk groups

1 finding from 1 review

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults,… 2021 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 602 participants
Moderate

Intervention not reported

Xpert MTB/RIF, non‐hospitalized people in high‐risk groups · people living with HIV and non‐hospitalized people in high‐risk groups

1 finding from 1 review

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults,… 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 337 participants
Low

Intervention not reported

Xpert MTB/RIF · people in high‐risk groups

1 finding from 1 review

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults,… 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 20 participants
Very low

Intervention not reported

True‐negatives (patients without pleural TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 240 participants
Very low

Intervention not reported

False‐positives (patients incorrectly classified as having pleural TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 240 participants
Very low

Intervention not reported

True‐positives (patients with lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Intervention not reported

False‐negatives (patients incorrectly classified as not having lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Intervention not reported

True‐negatives (patients without lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low

Intervention not reported

False‐positives (patients incorrectly classified as having lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low

Intervention not reported

True‐positives (participants with TB meningitis)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 89 participants
Low

Intervention not reported

True‐positives (patients correctly classified as rifampicin resistant)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 24 participants
Low

Intervention not reported

False‐negatives (patients incorrectly classified as rifampicin susceptible)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 24 participants
Low

Intervention not reported

True‐negatives (patients correctly classified as rifampicin susceptible)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 105 participants
Moderate

Intervention not reported

False‐positives (patients incorrectly classified as rifampicin resistant)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 105 participants
Moderate